Relapse free survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Lymph Nodes Cells, Cultured

Organisms1

Mice, Inbred C57BL

Diseases42

Neoplasm Recurrence, Local Breast Neoplasms Recurrence Lung Neoplasms Neoplasm Metastasis Lymphatic Metastasis Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Adenocarcinoma Liver Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm, Residual Brain Neoplasms Neoplasm Invasiveness Hodgkin Disease Colorectal Neoplasms Carcinoma, Squamous Cell Ovarian Neoplasms Lymphoma, Non-Hodgkin Carcinoma Bone Neoplasms Carcinoma, Hepatocellular Multiple Myeloma Kidney Neoplasms Sarcoma Prostatic Neoplasms Nasopharyngeal Neoplasms Leukemia, Myeloid, Acute Neoplasms, Glandular and Epithelial Carcinoma, Ductal, Breast Glioblastoma Gastrointestinal Neoplasms Urinary Bladder Neoplasms Pancreatic Neoplasms Carcinoma, Renal Cell Head and Neck Neoplasms Stomach Neoplasms Postoperative Complications Graft vs Host Disease Acute Disease Leukemic Infiltration Disease Models, Animal

Chemicals and Drugs37

Tumor Markers, Biological Antineoplastic Agents Cyclophosphamide Vincristine Cisplatin Fluorouracil Free Radicals Doxorubicin Methotrexate Prednisone Etoposide Receptor, erbB-2 Receptors, Estrogen Cytarabine Carboplatin Receptors, Progesterone Antineoplastic Agents, Alkylating Deoxycytidine Antimetabolites, Antineoplastic Organoplatinum Compounds Antibodies, Monoclonal, Humanized Leucovorin Antibodies, Monoclonal, Murine-Derived Ki-67 Antigen Antibodies, Monoclonal Neoplasm Proteins Paclitaxel Ifosfamide RNA, Messenger Taxoids Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Protein Kinase Inhibitors Tamoxifen Receptor, Epidermal Growth Factor Immunosuppressive Agents Angiogenesis Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment55

Prognosis Disease-Free Survival Neoplasm Staging Survival Rate Follow-Up Studies Retrospective Studies Survival Analysis Treatment Outcome Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Proportional Hazards Models Remission Induction Chemotherapy, Adjuvant Prospective Studies Radiotherapy, Adjuvant Multivariate Analysis Immunohistochemistry Neoplasm Grading Salvage Therapy Risk Factors Drug Administration Schedule Cohort Studies Predictive Value of Tests Transplantation, Homologous Neoadjuvant Therapy Radiotherapy Dosage Hematopoietic Stem Cell Transplantation Transplantation, Autologous Chemoradiotherapy Dose Fractionation Radiotherapy Clinical Trials as Topic Risk Assessment Lymph Node Excision Bone Marrow Transplantation Radiotherapy, Intensity-Modulated Immunoenzyme Techniques Peripheral Blood Stem Cell Transplantation Tumor Burden Randomized Controlled Trials as Topic Registries Reverse Transcriptase Polymerase Chain Reaction Radiotherapy, Conformal Gene Expression Profiling Tissue Array Analysis Brachytherapy Actuarial Analysis Chi-Square Distribution Risk Life Tables Prostatectomy Treatment Failure Transplantation Conditioning Disease Models, Animal

Psychiatry and Psychology1

Behavior, Addictive

Phenomena and Processes12

Cell Survival Time Factors Graft Survival Gene Expression Regulation, Neoplastic Apoptosis Drug Resistance, Neoplasm Dose-Response Relationship, Drug Cell Proliferation Mutation Signal Transduction Chi-Square Distribution Risk

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science5

Survival Rate Radiotherapy, Intensity-Modulated Registries Radiotherapy, Conformal Life Tables

Health Care23

Disease-Free Survival Survival Rate Follow-Up Studies Retrospective Studies Survival Analysis Treatment Outcome Kaplan-Meier Estimate Proportional Hazards Models Prospective Studies Multivariate Analysis Risk Factors Cohort Studies Predictive Value of Tests Age Factors Clinical Trials as Topic Risk Assessment Randomized Controlled Trials as Topic Registries Actuarial Analysis Chi-Square Distribution Risk Life Tables Treatment Failure

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Prognosis Disease-Free Survival Neoplasm Staging Neoplasm Recurrence, Local Survival Rate Follow-Up Studies Retrospective Studies Breast Neoplasms Cell Survival Survival Analysis Treatment Outcome Recurrence Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Survival Time Factors Proportional Hazards Models Graft Survival Tumor Markers, Biological Antineoplastic Agents Remission Induction Chemotherapy, Adjuvant Prospective Studies Lung Neoplasms Radiotherapy, Adjuvant Neoplasm Metastasis Cyclophosphamide Multivariate Analysis Lymphatic Metastasis Vincristine Immunohistochemistry Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm Grading Cisplatin Fluorouracil Salvage Therapy Risk Factors Free Radicals Drug Administration Schedule Adenocarcinoma Doxorubicin Cohort Studies Predictive Value of Tests Liver Neoplasms Transplantation, Homologous Methotrexate Carcinoma, Non-Small-Cell Lung Prednisone Neoadjuvant Therapy Etoposide Radiotherapy Dosage Neoplasm, Residual Brain Neoplasms Hematopoietic Stem Cell Transplantation Neoplasm Invasiveness Hodgkin Disease Transplantation, Autologous Colorectal Neoplasms Carcinoma, Squamous Cell Ovarian Neoplasms Receptor, erbB-2 Lymphoma, Non-Hodgkin Chemoradiotherapy Gene Expression Regulation, Neoplastic Receptors, Estrogen Cell Line, Tumor Carcinoma Cytarabine Dose Fractionation Age Factors Bone Neoplasms Radiotherapy Carboplatin Receptors, Progesterone Carcinoma, Hepatocellular Multiple Myeloma Clinical Trials as Topic Apoptosis Antineoplastic Agents, Alkylating Deoxycytidine Kidney Neoplasms Antimetabolites, Antineoplastic Organoplatinum Compounds Drug Resistance, Neoplasm Risk Assessment Dose-Response Relationship, Drug Antibodies, Monoclonal, Humanized Leucovorin Sarcoma Antibodies, Monoclonal, Murine-Derived Ki-67 Antigen Cell Proliferation Prostatic Neoplasms Lymph Node Excision Bone Marrow Transplantation Radiotherapy, Intensity-Modulated Mutation Immunoenzyme Techniques

No FAQ available that match "relapse free survival"